Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

RNA Therapies

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Closing the Developability Gap for RNA Therapeutics and Vaccines with a Fit-for-Purpose Analysis Kit

RNA

Closing the Developability Gap for RNA Therapeutics and Vaccines with a Fit-for-Purpose Analysis Kit

Susan Darling; Quincy Mehta

SCIEX

PAO-07-022-CL-06July 19, 2022

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-03-022-NI-02March 23, 2022

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Lipid Nanoparticles

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Natalia Zisman

Evonik

PAO-07-21-CL-02July 12, 2021

Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery

mRNA Therapies

Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery

Shiksha Mantri, Ph.D.

MilliporeSigma

PAO-06-21-CL-08June 16, 2021

Tackling Genetic Eye Diseases with Novel RNA Therapies

Ophthalmology

Tackling Genetic Eye Diseases with Novel RNA Therapies

Daniel A. de Boer

ProQR Therapeutics

PAP-Q4-19-CL-027December 06, 2019